Cited by 852Tryptophan and brain disordersSchizophrenia research and treatmentStress Responses and Cortisol

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life: A Population-Based Longitudinal Study

Open access

Khandaker, Golam M., Pearson, Rebecca M., Zammit, Stanley, Lewis, Glyn, Jones, Peter B.·2014·JAMA Psychiatry

DOI 10.1001/jamapsychiatry.2014.1332PMC PMC4561502

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Longitudinal studies have linked the systemic inflammatory markers interleukin 6 (IL-6) and C-reactive protein (CRP) with the risk of developing heart disease and diabetes mellitus, which are common comorbidities for depression and psychosis. Recent meta-analyses of cross-sectional studies have reported increased serum levels of these inflammatory markers in depression, first-episode psychosis, and acute psychotic relapse; however, the direction of the association has been unclear. OBJECTIVE: To test the hypothesis that higher serum levels of IL-6 and CRP in childhood would increase future risks for depression and psychosis. DESIGN, SETTING, AND PARTICIPANTS: The Avon Longitudinal Study of Parents and Children (ALSPAC)is a prospective general population birth cohort study based in Avon County, England. We have studied a subsample of approximately 4500 individuals from the cohort with data on childhood IL-6 and CRP levels and later psychiatric assessments. MEASUREMENT OF EXPOSURE: Levels of IL-6 and CRP were measured in nonfasting blood samples obtained in participants at age 9 years. MAIN OUTCOMES AND MEASURES: Participants were assessed at age 18 years. Depression was measured using the Clinical Interview Schedule-Revised (CIS-R) and Mood and Feelings Questionnaire (MFQ), thus allowing internal replication; psychotic experiences (PEs) and psychotic disorder were measured by a semistructured interview. RESULTS: After adjusting for sex, age, body mass index, ethnicity, social class, past psychological and behavioral problems, and maternal postpartum depression, participants in the top third of IL-6 values compared with the bottom third at age 9 years were more likely to be depressed (CIS-R) at age 18 years (adjusted odds ratio [OR], 1.55; 95% CI, 1.13-2.14). Results using the MFQ were similar. Risks of PEs and of psychotic disorder at age 18 years were also increased with higher IL-6 levels at baseline (adjusted OR, 1.81; 95% CI, 1.01-3.28; and adjusted OR, 2.40; 95% CI, 0.88-6.22, respectively). Higher IL-6 levels in childhood were associated with subsequent risks of depression and PEs in a dose-dependent manner. CONCLUSIONS AND RELEVANCE: Higher levels of the systemic inflammatory marker IL-6 in childhood are associated with an increased risk of developing depression and psychosis in young adulthood. Inflammatory pathways may provide important new intervention and prevention targets for these disorders. Inflammation might explain the high comorbidity between heart disease, diabetes mellitus, depression, and schizophrenia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamapsychiatry.2014.1332

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
The Strengths and Difficulties Questionnaire: A research note
Goodman, R. (1997) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1997.tb01545.x · Cited by 14,908
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953

Flagged first, then by citations

Show all 45 references

Research works printed but not linked: 1

[32]World Health Organization SCAN: Schedules for Clinical Assessment in Neuropsychiatry, Version 2.0 1994 Psychiatric Publishers International/American Psychiatric Press Inc Geneva, Switzerland

Sorted by citations

Items 101–200 of 852

Depression: Biological markers and treatment
Erjavec, G. N., Šagud, M., Perković, M. N., Štrac, D. Š., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 127
Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship
Rodrígues-Amorím, D., Baltanás, T. R., Spuch, C., Caruncho, H. J., González‐Fernández, Á., Olivares, J. M., & Agís‐Balboa, R. C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.11.023 · Cited by 120
Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression
Lasselin, J., Lekander, M., Benson, S., Schedlowski, M., & Engler, H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00869-2 · Cited by 121
The kynurenine pathway in major depression: What we know and where to next
Brown, S. J., Huang, X., & Newell, K. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.018 · Cited by 119
Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression
Verduijn, J., Milaneschi, Y., Schoevers, R. A., van Hemert, A. M., Beekman, A. T. F., & Penninx, B. W. J. H. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.137 · Cited by 126
Cortisol awakening response in patients with psychosis: systematic review and meta-analysis
Berger, M., Kraeuter, A. K., Romanik, D., Malouf, P., Amminger, G. P., & Sarnyai, Z. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.027 · Cited by 109
Prenatal maternal depression is associated with offspring inflammation at 25 years: a prospective longitudinal cohort study
Plant, D. T., Pawlby, S., Sharp, D., Zunszain, P. A., & Pariante, C. M. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.155 · Cited by 108
Infections and exposure to anti‐infective agents and the risk of severe mental disorders: a nationwide study
Köhler‐Forsberg, O., Petersen, L. V., Mors, O. N., Mortensen, P. B., Yolken, R. H., Gasse, C., & Benros, M. E. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12671 · Cited by 109
Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis
Misiak, B., Bartoli, F., Carrà, G., Stańczykiewicz, B., Gładka, A., Frydecka, D., Samochowiec, J., Jarosz, K., Hadryś, T., & Miller, B. J. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105200 · Cited by 107
Inflaming sex differences in mood disorders
Rainville, J. R., & Hodes, G. E. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0124-7 · Cited by 112
Immune mechanisms of depression in rheumatoid arthritis
Brock, J., Basu, N., Schlachetzki, J. C. M., Schett, G. A., McInnes, I. B., & Cavanagh, J. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01037-w · Cited by 108
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Orsolini, L., Sarchione, F., Vellante, F., Fornaro, M., Matarazzo, I., Martinotti, G., Valchera, A., Nicola, M. D., Carano, A., Giannantonio, M. D., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180119144538 · Cited by 102
Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression
Medina-Rodriguez, E. M., Lowell, J. A., Worthen, R. J., Syed, S. A., & Beurel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00547 · Cited by 106
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence
Mongan, D., Föcking, M., Healy, C., Susai, S. R., Heurich, M., Wynne, K. J., Nelson, B., McGorry, P. D., Amminger, G. P., Nordentoft, M., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2459 · Cited by 102
Self-citation
The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus
Wang, N., Yu, H., Shen, X., Gao, Z., Yang, C., Yang, J., & Zhang, G.-F. (2015) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2015.1060281 · Cited by 103
Dietary Inflammatory Index and Recurrence of Depressive Symptoms
Akbaraly, T. N., Kerleau, C., Wyart, M., Chevallier, N., Ndiaye, L., Shivappa, N., Hébert, J. R., & Mika Kivimaki, B. (2016) · Clinical Psychological Science · doi:10.1177/2167702616645777 · Cited by 101
Dysconnectivity of a brain functional network was associated with blood inflammatory markers in depression
Aruldass, A. R., Kitzbichler, M. G., Morgan, S. E., Lim, S. I., Lynall, M.-E., Turner, L., Vértes, P. E., Cavanagh, J., Cowen, P. J., Pariante, C. M., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.226 · Cited by 103
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Kopra, E. I., Mondelli, V., Pariante, C. M., & Nikkheslat, N. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026426 · Cited by 106
Sulforaphane produces antidepressant- and anxiolytic-like effects in adult mice
Wu, S., Gao, Q., Zhao, P., Gao, Y., Xi, Y., Wang, X., Liang, Y., Shi, H., & Ma, Y. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.030 · Cited by 97
Role of inflammation in depression and anxiety: Tests for disorder specificity, linearity and potential causality of association in the UK Biobank
Ye, Z., Kappelmann, N., Moser, S., Smith, G. D., Burgess, S., Jones, P. B., & Khandaker, G. M. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100992 · Cited by 105
Self-citation
Inflammation and depression in young people: a systematic review and proposed inflammatory pathways
Toenders, Y. J., Laskaris, L., Davey, C. G., Berk, M., Milaneschi, Y., Lamers, F., Penninx, B. W. J. H., & Schmaal, L. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01306-8 · Cited by 106
miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction
Woodbury, M. E., Freilich, R. W., Cheng, C. J., Asai, H., Ikezu, S., Boucher, J. D., Slack, F. J., & Ikezu, T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4790-14.2015 · Cited by 96
Is it time for immunopsychiatry in psychotic disorders?
Leboyer, M., Oliveira, J., Tamouza, R., & Groc, L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4266-1 · Cited by 98
Clinical studies of neuroinflammatory mechanisms in schizophrenia
Watkins, C. C., & Andrews, S. R. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.018 · Cited by 101
Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
Savitz, J. B. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_12 · Cited by 98
The connection between microbiome and schizophrenia
Golofast, B., & Vales, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.011 · Cited by 92
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Fond, G. B., Lançon, C., Auquier, P., & Boyer, L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00392 · Cited by 95
Serum kynurenic acid is reduced in affective psychosis
Wurfel, B. E., Drevets, W. C., Bliss, S. A., McMillin, J. R., Suzuki, H., Ford, B. N., Morris, H. M., Teague, T. K., Dantzer, R., & Savitz, J. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.88 · Cited by 91
Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS: Attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior
Frank, M. G., Fonken, L. K., Dolzani, S. D., Annis, J. L., Siebler, P. H., Schmidt, D., Watkins, L. R., Maier, S. F., & Lowry, C. A. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.020 · Cited by 101
The old friends hypothesis: evolution, immunoregulation and essential microbial inputs
Rook, G. A. W. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1220481 · Cited by 95
Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
Borovčanin, M., Jovanović, I., Radosavljevic, G. D., Pantic, J. M., Janicijevic, S. M., Arsenijević, N., & Lukić, M. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00221 · Cited by 92
The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study
Perry, B. I., Burgess, S., Jones, H. J., Zammit, S., Upthegrove, R., Mason, A. M., Day, F. R., Langenberg, C., Wareham, N. J., Jones, P. B., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003455 · Cited by 91
Self-citation
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders
Frye, M. A., Nassan, M. M., Jenkins, G. D., Kung, S., Veldić, M., Palmer, B. A., Feeder, S. E., Tye, S. J., Choi, D., & Biernacka, J. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.185 · Cited by 89
Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
Sethi, R., Gómez‐Coronado, N., Walker, A. J., Robertson, O. D., Agustini, B., Berk, M., & Dodd, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00605 · Cited by 90
Peripheral inflammation is associated with micro-structural and functional connectivity changes in depression-related brain networks
Kitzbichler, M. G., Aruldass, A. R., Barker, G. J., Wood, T., Dowell, N. G., Hurley, S. A., McLean, J., Correia, M., Clarke, C., Pointon, L. J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01272-1 · Cited by 93
The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
Petralia, M. C., Mazzon, E., Fagone, P., Basile, M. S., Lenzo, V., Quattropani, M. C. A., Nuovo, S. D., Bendtzen, K., & Nicoletti, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102504 · Cited by 89
The burden of disease in early schizophrenia – a systematic literature review
Crespo‐Facorro, B., Such, P., Nylander, A., Madera‐McDonough, J., Resemann, H. K., Worthington, E., O'Connor, M., Drane, E., Steeves, S., & Newton, R. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1841618 · Cited by 93
The Link Between the Immune System, Environment, and Psychosis
Radhakrishnan, R., Kaşer, M., & Gülöksüz, S. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx057 · Cited by 82
Less immune activation following social stress in rural vs. urban participants raised with regular or no animal contact, respectively
Böbel, T. S., Hackl, S. B., Langgartner, D., Jarczok, M. N., Rohleder, N., Rook, G. A. W., Lowry, C. A., Gündel, H., Waller, C., & Reber, S. O. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719866115 · Cited by 84
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 87
Esketamine alleviates postoperative depression-like behavior through anti-inflammatory actions in mouse prefrontal cortex
Wang, T., Weng, H., Zhou, H., Yang, Z., Tian, Z., Xi, B., & Li, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.072 · Cited by 81
Is depression the missing link between inflammatory mediators and cancer?
Polityńska, B., Pokorska, O., Wojtukiewicz, A. M., Sawicka, M., Mysliwiec, M., Honn, K. V., Tucker, S. C., & Wojtukiewicz, M. Z. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108293 · Cited by 83
The human physiology of well-being: A systematic review on the association between neurotransmitters, hormones, inflammatory markers, the microbiome and well-being
de Vries, L. P., van de Weijer, M. P., & Bartels, M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104733 · Cited by 85
Longitudinal pathways between childhood BMI, body dissatisfaction, and adolescent depression: an observational study using the UK Millennium Cohort Study
Blundell, E., Stavola, B. L. D., Kellock, M. D., Kelly, Y. J., Lewis, G., McMunn, A., Nicholls, D., Patalay, P., & Solmi, F. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00365-6 · Cited by 77
Self-citation
Glia in the cytokine-mediated onset of depression: fine tuning the immune response
Jo, W. K., Zhang, Y., Emrich, H. M., & Dietrich, D. E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00268 · Cited by 81
Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
Radtke, F., Chapman, G., Hall, J., & Syed, Y. A. (2017) · BioMed Research International · doi:10.1155/2017/5071786 · Cited by 80
Inflammation, Antipsychotic Drugs, and Evidence for Effectiveness of Anti-inflammatory Agents in Schizophrenia
Pandurangi, A. K., & Buckley, P. F. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_91 · Cited by 76
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill
Knight, J. M., Costanzo, E. S., Singh, S., Yin, Z., Szabó, A., Pawar, D. S., Hillard, C. J., Rizzo, J. D., D’Souza, A., Pasquini, M. C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01164-y · Cited by 79
Increased neutrophil-lymphocyte ratios in depressive adolescents is correlated with the severity of depression
Özyurt, G., & Binici, N. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.007 · Cited by 74
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis
Park, S., & Miller, B. J. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.012 · Cited by 75
Investigational drugs in recent clinical trials for treatment-resistant depression
Garay, R. P., Zarate, C. A., Charpeaud, T., Citrome, L., Correll, C. U., Hameg, A., & Llorca, P. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1283217 · Cited by 76
Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation
Khandaker, G. M., Oltean, B. P., Kaşer, M., Dibben, C. R. M., Ramana, R., Jadon, D. R., Dantzer, R., Coles, A. J., Lewis, G., & Jones, P. B. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-025333 · Cited by 74
Self-citation
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Graham, C., Velasco, R., Tomás, A. A., Stewart, O., Dachy, G., Bufalo, F. D., Doglio, M., Henter, J., Ortí, G., Perić, Z., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00715-0 · Cited by 77
Immuno-psychiatry: an agenda for clinical practice and innovative research
Leboyer, M., Berk, M., Yolken, R. H., Tamouza, R., Kupfer, D. J., & Groc, L. (2016) · BMC Medicine · doi:10.1186/s12916-016-0712-5 · Cited by 74
Deciphering sex differences in the immune system and depression
Rainville, J. R., Tsyglakova, M., & Hodes, G. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.12.004 · Cited by 73
Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression
Müller, N., Krause, D., Barth, R., Myint, A.-M., Weidinger, E., Stettinger, W., Zill, P., Drexhage, H. A., & Schwarz, M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.088 · Cited by 75
Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention
Zhou, J., Fangma, Y., Chen, Z., & Zheng, Y. (2023) · Aging and Disease · doi:10.14336/ad.2023.0310-2 · Cited by 85
Unraveling the Complex Interplay Between Neuroinflammation and Depression: A Comprehensive Review
Sălcudean, A., Popovici, R. A., Pitic, D. E., Sârbu, D., Boroghina, A. R., Jomaa, M., Salehi, M. A., Kher, A. A. M., Lica, M. M., Bodo, C. R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041645 · Cited by 82
Old Friends, immunoregulation, and stress resilience
Langgartner, D., Lowry, C. A., & Reber, S. O. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2228-7 · Cited by 76
Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder
Miller, B. J., & Goldsmith, D. R. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200015 · Cited by 73
Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real‐world observational study
Vanasse, A., Blais, L., Courteau, J., Cohen, A. A., Roberge, P., Larouche, A., Grignon, S., Fleury, M., LESAGE, A. D., Demers, M., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12621 · Cited by 72
Stress-Related Dysfunction of Adult Hippocampal Neurogenesis—An Attempt for Understanding Resilience?
Leschik, J., Lutz, B., & Gentile, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147339 · Cited by 77
The inflammatory underpinning of depression: An historical perspective
Yirmiya, R. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.048 · Cited by 76
Evidence for Immune Activation and Resistance to Glucocorticoids Following Childhood Maltreatment in Adolescents Without Psychopathology
do Prado, C. H., Grassi‐Oliveira, R., Daruy-Filho, L., Wieck, A., & Bauer, M. E. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.137 · Cited by 69
Repeated exposure to systemic inflammation and risk of new depressive symptoms among older adults
Bell, J. A., Mika Kivimaki, B., Bullmore, E. T., Steptoe, A., Bullmore, E. T., Vértes, P. E., Cardinal, R. N., Richardson, S. T., Leday, G., Freeman, T., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.155 · Cited by 67
Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case–Control Study of the ALSPAC Longitudinal Birth Cohort
English, J. A., Lopez, L. M., O’Gorman, A., Föcking, M., Hryniewiecka, M., Scaife, C., Sabherwal, S., Wynne, K. J., Dicker, P., Rutten, B. P. F., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx075 · Cited by 70
Self-citation
Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study
Huang, M., Su, S., Goldberg, J. H., Miller, A. H., Levantsevych, O. M., Shallenberger, L. H., Pimple, P. M., Pearce, B. D., Bremner, J. D., & Vaccarino, V. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.10.007 · Cited by 66
Corrigendum: Quercetin Alleviates LPS-Induced Depression-Like Behavior in Rats via Regulating BDNF-Related Imbalance of Copine 6 and TREM1/2 in the Hippocampus and PFC
Fang, K., Li, H., Chen, X.-X., Gao, X., Huang, L.-L., Du, A.-Q., Jiang, C., Li, H., & Ge, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00518 · Cited by 72
Folate and Its Significance in Depressive Disorders and Suicidality: A Comprehensive Narrative Review
Liwinski, T., & Lang, U. E. (2023) · Nutrients · doi:10.3390/nu15173859 · Cited by 77
Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology
Miller, B. J., & Goldsmith, D. R. (2019) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2019.100006 · Cited by 72
How handling extreme C-reactive protein (CRP) values and regularization influences CRP and depression criteria associations in network analysesPreprint
Moriarity, D. P., Horn, S. R. G.-V., Kautz, M. M., Haslbeck, J. M. B., & Alloy, L. B. (2020) · PsyArXiv (OSF Preprints) · doi:10.1016/j.bbi.2020.10.020 · Cited by 70
Elevated levels of Hs-CRP and IL-6 after delivery are associated with depression during the 6 months post partum
Liu, H., Zhang, Y., Gao, Y., & Zhang, Z. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.022 · Cited by 73
Gender differences in longitudinal relationships between depression and anxiety symptoms and inflammation in the health and retirement study
Niles, A. N., Smirnova, M., Lin, J. E., & O’Donovan, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.035 · Cited by 69
The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders
Labad, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.028 · Cited by 67
Bidirectional Associations Between Inflammatory Biomarkers and Depressive Symptoms in Adolescents: Potential Causal Relationships
Moriarity, D. P., Kautz, M. M., Giollabhui, N. M., Klugman, J., Coe, C. L., Ellman, L. M., Abramson, L. Y., & Alloy, L. B. (2020) · Clinical Psychological Science · doi:10.1177/2167702620917458 · Cited by 69
Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: findings from the ALSPAC cohort
Khandaker, G. M., Zammit, S., Lewis, G., & Jones, P. B. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.02.003 · Cited by 65
Self-citation
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 68
Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study
Khandaker, G. M., Štochl, J., Zammit, S., Goodyer, I. M., Lewis, G., & Jones, P. B. (2017) · Psychological Medicine · doi:10.1017/s0033291717003038 · Cited by 67
Self-citation
Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment
Zuelli, F. M. D. G. C., Loureiro, C. M., Shuhama, R., Fachim, H., Menezes, P. R., Louzada‐Júnior, P., Mondelli, V., & Del‐Ben, C. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719001016 · Cited by 66
Disruption of the blood–brain barrier in 22q11.2 deletion syndrome
Crockett, A. M., Ryan, S. K., Vásquez, A. H., Canning, C., Kanyuch, N., Kébir, H., Ceja, G., Gesualdi, J., Zackai, E. H., McDonald‐McGinn, D. M., et al. (2021) · Brain · doi:10.1093/brain/awab055 · Cited by 62
Longitudinal relationships of cytokines, depression and anhedonia in depressed adolescents
Rengasamy, M. L., Marsland, A. L., McClain, L. L., Kovats, T., Walko, T. D., Pan, L. A., & Price, R. B. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.004 · Cited by 65
Association of systemic inflammatory biomarkers with depression risk: Results from National Health and Nutrition Examination Survey 2005–2018 analyses
Li, X., Huan, J.-M., Lin, L., & Hu, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1097196 · Cited by 66
Inflammation-related epigenetic risk and child and adolescent mental health: A prospective study from pregnancy to middle adolescence
Barker, E. D., Cecil, C. A. M., Walton, E., Houtepen, L. C., O’Connor, T. G., Danese, A., Jaffee, S. R., Jensen, S. K. G., Pariante, C. M., McArdle, W. L., et al. (2018) · Development and Psychopathology · doi:10.1017/s0954579418000330 · Cited by 65
Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions
Han, Y., Yuan, K., Wang, Z., Liu, W., Lu, Z.-A., Liu, L., Shi, L., Yan, W., Yuan, J., Li, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01629-8 · Cited by 67
Psiconeuroinmunología de los trastornos mentales
Soria, V., Uribe, J., Salvat‐Pujol, N., Palao, D. J., Menchón, J. M., & Labad, J. (2017) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2017.07.006 · Cited by 68
Back to the future of psychoneuroimmunology: Studying inflammation-induced sickness behavior
Lasselin, J. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100379 · Cited by 68
Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia
Şimşek, Ş., Yıldırım, V., Çim, A., & Kaya, S. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0220 · Cited by 62
Pathways between early‐life adversity and adolescent self‐harm: the mediating role of inflammation in the Avon Longitudinal Study of Parents and Children
Russell, A. E., Heron, J., Gunnell, D., Ford, T. J., Hemani, G., Joinson, C. J., Moran, P., Relton, C. L., Suderman, M. J., & Mars, B. (2019) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13100 · Cited by 62
The Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort as a resource for studying psychopathology in childhood and adolescence: a summary of findings for depression and psychosis
Niarchou, M., Zammit, S., & Lewis, G. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1072-8 · Cited by 65
Self-citation
Physiological Rhythms and Biological Variation of Biomolecules: The Road to Personalized Laboratory Medicine
Coskun, A., Zarepour, A., & Zarrabi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076275 · Cited by 61
Inflammation as the Potential Basis in Depression
Maeng, S., & Hong, H. (2019) · International Neurourology Journal · doi:10.5213/inj.1938226.113 · Cited by 64
Hyper-inflammation of astrocytes in patients of major depressive disorder: Evidence from serum astrocyte-derived extracellular vesicles
Xie, X., Lai, W., Xu, S., Forti, M. D., Zhang, J., Chen, M., Yao, L., Wang, P., Hao, K., & Rong, H. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.12.014 · Cited by 62
Sleep, circadian rhythms, and schizophrenia
Cosgrave, J., Wulff, K., & Gehrman, P. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000419 · Cited by 63
Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Liberman, A. C., Trías, E., Chagas, L. D. S., Trindade, P., Pereira, M. D. S., Refojo, D., Hedin‐Pereira, C., & Serfaty, C. A. (2018) · NeuroImmunoModulation · doi:10.1159/000494761 · Cited by 62
Combined Effect of TLR2 Gene Polymorphism and Early Life Stress on the Age at Onset of Bipolar Disorders
Oliveira, J., Étain, B., Lajnef, M., Hamdani, N., Bennabi, M., Bengoufa, D., Sundaresh, A., Chaabene, A. B., Bellivier, F., Henry, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119702 · Cited by 60
There is an association between serum high-sensitivity C-reactive protein (hs-CRP) concentrations and depression score in adolescent girls
Tabatabaeizadeh, S.-A., Abdizadeh, M. F., Meshkat, Z., Khodashenas, E., Darroudi, S., Fazeli, M., Ferns, G. A., Avan, A., & Ghayour-Mobarhan, M. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.11.014 · Cited by 55
Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis
Bustan, Y., Drapisz, A., Dor, D. H. B., Avrahami, M., Schwartz-Lifshitz, M., Weizman, A., & Barzilay, R. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.002 · Cited by 57
Dysglycaemia, Inflammation and Psychosis: Findings From the UK ALSPAC Birth Cohort
Perry, B. I., Upthegrove, R., Thompson, A. D., Marwaha, S., Zammit, S., Singh, S. P., & Khandaker, G. M. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby040 · Cited by 55
Self-citation
Inflamed depression
Bullmore, E. T. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32356-0 · Cited by 56

Authors: Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B.
Affiliations: National Health Service (GB)
University of Bristol (GB)
Corresponding author: Khandaker, Golam M.
ORCID: Khandaker, Golam M.
Pearson, Rebecca M.
Zammit, Stanley
Lewis, Glyn
Jones, Peter B.
Venue: JAMA Psychiatry
Publisher: American Medical Association (AMA)
Published: 2014-10-01
Volume: 71
Issue: 10
Pages: 1121
ISSN: 2168-622X (ISSN-L)
DOI: 10.1001/jamapsychiatry.2014.1332
PMC: PMC4561502
OpenAlex: W2134549690
Cited by: 846
References: 45
Citations by year: 2026: 85 · 2025: 66 · 2024: 75 · 2023: 81 · 2022: 72 · 2021: 102 · 2020: 100 · 2019: 70 · 2018: 52 · 2017: 57 · 2016: 48 · 2015: 35 · 2014: 3
FWCI: 14.58
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA Psychiatry (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
Explore Bristol Research (submittedVersion)
Funders: Wellcome Trust (088869/Z/09/Z, 095844/Z/11/Z, 102215, 092731, 095844, 084268/Z/07/Z)
National Institute for Health and Care Research (RP-PG-0606-1335)
Medical Research Council (MR/L010305/1, MC_PC_15018)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords: interleukin-6, C-reactive protein, depression, psychosis, psychotic experiences, inflammatory markers, early adulthood, Avon Longitudinal Study of Parents and Children, dose-response relationship, postpartum depression, psychiatric comorbidity, cardiovascular comorbidity, diabetes comorbidity, first-episode psychosis, psychotic relapse
MeSH terms: Adolescent, C-Reactive Protein, Child, Depression, England, Female, Humans, Interview, Psychological, Male, Prospective Studies, Psychiatric Status Rating Scales, Psychotic Disorders, Risk Factors, Biomarkers, Interleukin-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life: A Population-Based Longitudinal Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks